EHRA 25: New Insights into VT Substrate Identification

1 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
EHRA 2025 - We are joined onsite at EHRA Congress 2025 by Prof Pier Lambiase to discuss the latest developments in ventricular tachycardia substrate identification from the EHRA Ablation Summit 2025.

Interview Questions:
What are the key challenges or limitations that still exist in accurately identifying VT substrates?
What are the most significant recent advancements in techniques or technologies for identifying VT substrates, and how do they improve upon previous methods?
How are these new insights into VT substrate identification influencing current clinical practices in the management and treatment of VT?
How do these advancements in VT substrate identification directly benefit patients, particularly in terms of treatment outcomes and quality of life?
What are the most promising areas of research or development in VT substrate identification, and how might they shape the future of arrhythmia management?
Marketing: Could you sum up the key takeaways from the ablation summit, in terms of VT Substrate identification, in a few sentences?

Recorded Onsite at EHRA Congress 2025, Vienna.
Editors: Jordan Rance and Yazmin Sadik
Video Specialists: Oliver Miles
Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook: https://www.facebook.com/RadcliffeCardiology
Follow us on X: https://x.com/radcliffeCARDIO
Category
Cardiology
Be the first to comment

Up Next